EP 1154988 B1 20040811 - MEVINOLIN DERIVATIVES
Title (en)
MEVINOLIN DERIVATIVES
Title (de)
MEVINOLINDERIVATE
Title (fr)
DERIVES DE MEVINOLINE
Publication
Application
Priority
- EP 0001191 W 20000214
- GB 9903546 A 19990216
- GB 9927880 A 19991125
Abstract (en)
[origin: WO0048989A1] Mevinolin derivatives wherein the lactone ring is modified have interesting pharmaceutical properties, particularly in preventing or treating disorders or diseases mediated by LFA-1/ICAM-1 interactions.
IPC 1-7
C07C 235/26; C07C 237/18; C07C 235/30; C07C 237/20; C07D 211/76; C07D 265/24; C07D 401/06; A61K 31/4402; A61K 31/45; A61K 31/4545; A61K 31/535; A61P 9/10; A61P 3/06; A61P 29/00; A61P 37/00
IPC 8 full level
A61K 31/22 (2006.01); A61K 31/27 (2006.01); A61K 31/4402 (2006.01); A61K 31/45 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/4709 (2006.01); A61K 31/535 (2006.01); A61K 45/00 (2006.01); A61P 1/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/02 (2006.01); A61P 17/04 (2006.01); A61P 17/06 (2006.01); A61P 17/08 (2006.01); A61P 17/14 (2006.01); A61P 21/04 (2006.01); A61P 25/28 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07C 235/26 (2006.01); C07C 235/30 (2006.01); C07C 237/18 (2006.01); C07C 237/20 (2006.01); C07C 271/12 (2006.01); C07D 211/76 (2006.01); C07D 265/10 (2006.01); C07D 265/24 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01)
CPC (source: EP US)
A61P 1/04 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 5/14 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 17/04 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 17/08 (2017.12 - EP); A61P 17/14 (2017.12 - EP); A61P 21/04 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07C 235/26 (2013.01 - EP US); C07C 235/30 (2013.01 - EP US); C07C 237/18 (2013.01 - EP US); C07C 271/12 (2013.01 - EP US); C07D 211/76 (2013.01 - EP US); C07D 265/10 (2013.01 - EP US); C07C 2602/28 (2017.04 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0048989 A1 20000824; AR 022588 A1 20020904; AT E273272 T1 20040815; AU 3804000 A 20000904; AU 763357 B2 20030717; BR 0008292 A 20011106; CA 2361841 A1 20000824; CA 2361841 C 20081202; CN 1229335 C 20051130; CN 1340044 A 20020313; CO 5140104 A1 20020322; DE 60012888 D1 20040916; DE 60012888 T2 20050818; DK 1154988 T3 20041122; EP 1154988 A1 20011121; EP 1154988 B1 20040811; ES 2226802 T3 20050401; JP 2002537284 A 20021105; JP 4167806 B2 20081022; PE 20001495 A1 20010112; PT 1154988 E 20041231; SI 1154988 T1 20050228; US 2002037895 A1 20020328; US 2003087903 A1 20030508; US 6818638 B2 20041116
DOCDB simple family (application)
EP 0001191 W 20000214; AR P000100626 A 20000214; AT 00916832 T 20000214; AU 3804000 A 20000214; BR 0008292 A 20000214; CA 2361841 A 20000214; CN 00803817 A 20000214; CO 00008363 A 20000209; DE 60012888 T 20000214; DK 00916832 T 20000214; EP 00916832 A 20000214; ES 00916832 T 20000214; JP 2000599730 A 20000214; PE 0001142000 A 20000214; PT 00916832 T 20000214; SI 200030511 T 20000214; US 19288802 A 20020711; US 92859301 A 20010813